• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 418571 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419811556 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419811556 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Hot Stock: Oncothyreon, Shares Gain 6.7% (ONTY)

Published on Wed, 01/09/2013 - 13:22
By Adrienne Chilton

Oncothyreon (NASDAQ:ONTY) is one of today's best performing low-priced stocks, up 6.7% to $2.22 on 1.2x average daily volume. Thus far today, Oncothyreon has traded 2.8 million shares, vs. average volume of 2.4 million shares per day. The stock has outperformed the Dow (6.7% to the Dow's 0.4%) and outperformed the S&P 500 (6.7% to the S&P's 0.2%) during today's trading.

There is potential upside of 140.3% for shares of Oncothyreon based on a current price of $2.22 and an average consensus analyst price target of $5.33. The stock should run into initial resistance at its 50-day moving average (MA) of $3.96 and subsequent resistance at its 200-day MA of $4.37.

Oncothyreon Inc. is a biotechnology company that develops therapeutic approaches to cancer management. The Company focuses on the development of synthetic vaccines and strategies for immunotherapy of cancer.

In the past 52 weeks, Oncothyreon share prices have been bracketed by a low of $1.71 and a high of $11.59 and are now at $2.22, 30% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.9% while the 50-day MA has declined 4.5%.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

VeriFone Earnings In Retrospect: Up 15.2...

When VeriFone (NYSE:PAY) reported earnings a week ago on December 15th, 2014, analysts, ...

Earnings Look Back: Navistar Internation...

When Navistar International (NYSE:NAV) reported earnings a week ago on December 16th, 2 ...

Earnings Flashback: Since Reporting Quar...

Two weeks ago on December 8th, 2014 IDT (NYSE:IDT) reported earnings and analysts, on a ...

General Mills Earnings Review: 10 Days a...

When General Mills (NYSE:GIS) reported earnings 10 days ago on December 17th, 2014, ana ...

Post Earnings Update: Ferrellgas Partner...

17 days ago, on December 10th, 2014, Ferrellgas Partners (NYSE:FGP) reported its earnin ...

Post Earnings Update: Vail Resorts Has C...

Two weeks ago on December 8th, 2014 Vail Resorts (NYSE:MTN) reported earnings and analy ...

Earnings Look Back: Cantel Medical Is Do...

When Cantel Medical (NYSE:CMN) reported earnings two weeks ago on December 10th, 2014, ...

ABM Industries Earnings Hindsight: Up 8....

Two weeks ago on December 8th, 2014 ABM Industries (NYSE:ABM) reported earnings and ana ...